|
| Study (notes, conc values) | Percentile | PCB conc (ng/g lipid) | Min conc | Max conc | Case sample size | Control sample size | OR | 95% LCL | 95% UCL | Meta-analysis inclusion |
|
|
Rothman et al. 1997 (mean conc) [40] | Total | | | | 74 | 147 | | | | |
| 1 | 526 | 247 | 641 | 10 | 37 | 1.00 | | | |
| 2 | 727 | 649 | 806 | 13 | 37 | 1.30 | 0.5 | 3.3 | No |
| 3 | 924 | 814 | 1060 | 21 | 37 | 2.80 | 1.1 | 7.6 | |
| 4 | 1430 | 1070 | 2070 | 30 | 36 | 4.50 | 1.7 | 12.0 | |
|
|
Engel et al., 2007 (Janus cohort, median conc) [41] | Total | | | | 190 | 190 | | | | |
| 1 | 1048.3 | | | 44 | 48 | 1.00 | | | |
| 2 | 1398.3 | | | 48 | 47 | 1.10 | 0.7 | 2.0 | Yes |
| 3 | 1674.9 | | | 38 | 48 | 1.00 | 0.5 | 1.9 | |
| 4 | 2148.2 | | | 60 | 47 | 1.70 | 0.8 | 3.4 | |
|
|
Engel et al., 2007 (CLUE 1 cohort median conc) [41] | Total | | | | 74 | 147 | | | | |
| 1 | 551.4 | | | 10 | 37 | 1.00 | | | |
| 2 | 726 | | | 13 | 37 | 1.10 | 0.7 | 2.0 | Yes |
| 3 | 911.5 | | | 21 | 37 | 1.00 | 0.5 | 1.9 | |
| 4 | 1377.3 | | | 30 | 36 | 1.70 | 0.8 | 3.4 | |
|
|
Spinelli et al., 2007 (Median conc) [42] | Total | | | | 403 | | | | | |
| 1 | | <100.9 | 100.9 | 81 | 115 | 1.00 | | | |
| 2 | | >100.9 | 155.6 | 103 | 114 | 1.41 | 0.93 | 2.14 | Yes |
| 3 | | >155.6 | 220 | 77 | 115 | 1.11 | 0.71 | 1.74 | |
| 4 | | >220 | 6571 | 142 | 115 | 2.14 | 1.38 | 3.30 | |
|
|
De Roos et al., 2005 [26] | Total | | | | 97 | 96 | | | | |
| 1 | | <6.4 | 6.4 | 28 | 24 | 1.00 | | | |
| 2 | | >6.4 | 8.69 | 16 | 25 | 0.59 | 0.25 | 1.40 | Yes |
| 3 | | >8.69 | 13.17 | 20 | 23 | 0.86 | 0.38 | 1.98 | |
| 4 | | >13.17 | | 33 | 24 | 1.51 | 0.62 | 3.67 | |
|
| Laden et al., 2010 (median conc) [48] | Total | | | | 145 | 290 | | | | |
| 1 | 406.9 | | | 33 | 72 | 1.00 | | | |
| 2 | 547.8 | | | 41 | 73 | 1.22 | 0.69 | 2.18 | Yes |
| 3 | 678.0 | | | 41 | 73 | 1.22 | 0.69 | 2.18 | |
| 4 | 945.4 | | | 30 | 72 | 0.91 | 0.50 | 1.67 | |
|
|
Hardell et al., 2001 (36 PCBs, mean conc) [53] | Total | 1436 | 331 | 4706 | 82 | 83 | 1.00 | | | |
| 1 | | 1296 (med) | 4706 | 51 | 41 | 1.80 | 0.85 | 3.9 | No |
|
|
Hardell et al., 2001 (11 immunotoxic PCBs) [53] | Total | 511 | 118 | 1598 | 82 | 83 | 1.00 | | | |
| 1 | | 462 (med) | 1598 | 57 | 40 | 3.20 | 1.4 | 7.4 | No |
|
|
Hardell et al., 2006; [54] Hardell et al., 2009 [43] (all PCBs, mean conc) | Total | 860 | 102 | 4222 | 97 | 98 | 1.00 | | | |
| 1 | | 762 (med) | 4222 | 59 | 49 | 2.00 | 0.99 | 3.99 | No |
|
|
Hardell et al., 2006; [54] Hardell et al., 2009 [43] (11 immunotoxic PCBs) | Total | 290 | 41 | 1297 | 97 | 98 | 1.00 | | | |
| 1 | | 238 (med) | 1297 | 54 | 49 | 1.50 | 0.8 | 3.0 | No |
|
|
Cocco et al., 2008 [46] | Total | | | | 174 | | | | | |
| 1 | | <200.42 | 200.42 | 41 | 51 | 1.00 | | | |
| 2 | | 200.43 | 387.79 | 50 | 51 | 1.20 | 0.6 | 2.2 | Yes |
| 3 | | 387.8 | 576.36 | 33 | 50 | 0.70 | 0.3 | 1.4 | |
| 4 | | 576.37 | >576.37 | 50 | 51 | 1.00 | 0.5 | 2.0 | |
|
|
Quintana et al., 2004 [44] | Total | | | | | | | | | |
| 1 | | <1000 | 1000 | 79 | 184 | 1.00 | | | |
| 2 | | >1000 | 3000 | 50 | 151 | 1.05 | 0.63 | 1.76 | No |
| 3 | | >3000 | | 9 | 23 | 1.08 | 0.40 | 2.92 | |
|
| Bertrand et al., 2010 (median conc) [47] | Total | | | | 205 | 409 | | | | |
| 1 | 518 | 163 | 617 | 33 | 81 | 1..00 | | | |
| 2 | 678 | >617 | 742 | 31 | 82 | 0.92 | 0.51 | 1.60 | Yes |
| 3 | 815 | >742 | 894 | 34 | 82 | 1.00 | 0.60 | 1.80 | |
| 4 | 980 | >894 | 1121 | 46 | 82 | 1.40 | 0.71 | 2.20 | |
| 5 | 1385 | >1121 | 5322 | 61 | 82 | 1.90 | 0.94 | 2.90 | |
|